Benzo[ c ]acridine Dimer Cyclization as a Route toward a Small Bicationic Heteroaromatic Compound with Unprecedented G-Quadruplex Stabilization Properties
ACS Chemical Biology · 2026
DOI: 10.1021/acschembio.6c00586 ↗At a glance
Journal article in ACS Chemical Biology, 2026. Written by Stefanie Sandra Sandberg and 10 co-authors. Institution: Department of Medical Biochemistry and Biophysics, Umeå University, Umeå901 87, Sweden. Major MEDLINE topics: G-Quadruplexes, Acridines. 70 references. The full text is freely available (open access, CC BY 4.0). Funded by: Narodowe Centrum Nauki.
Abstract (original language)
G-quadruplex (G4) DNA structures are key regulatory elements in genome stability and gene expression, with a pronounced role in cancer biology due to their selective formation in oncogenic genomic regions and abundance in tumor cells. Their structural uniqueness makes them compelling targets for therapeutic intervention. Thus, targeting G4s with small molecule ligands offers a promising approach for modulating gene expression and inducing replication stress, particularly in DNA damage response-deficient malignancies such as ovarian and breast cancers. However, the structural diversity of G4s has hindered the development of ligands capable of broad-spectrum, topology-independent stabilization. Here, we introduce a novel dimeric N-methylbenzo[c]acridinium derivative, engineered as a visible-light-absorbing cationic G4 ligand. Compared to previously reported diazonia derivatives, this compound demonstrates red-shifted optical properties, superior luminescence quantum efficiency, and outstanding G4-stabilizing activity. It exhibits high preferential binding for G4s over dsDNA, induces conformational transitions between hybrid and antiparallel G4s, stalls DNA replication, and disrupts DNA duplex formation. Notably, its broad, topology-independent recognition enables stabilization of a range of G4 targets. Crucially, it surpasses benchmark G4 ligands, including PhenDC3 and CX-5461, in both selectivity and/or efficacy. These results support the dimeric benzo[c]acridinium scaffold as a versatile platform for the development of G4-targeted therapeutic strategies.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Medical Biochemistry and Biophysics, Umeå University, Umeå901 87, Sweden.
- CNRS, ENS de Lyon, LCH UMR 5182 , Lyon69007, France.
- ENS de Lyon, CNRS, LCH UMR 5182 , Lyon69007, France.
- Institute of Advanced Materials, Faculty of Chemistry, Wrocław University of Science and Technology, Wyb. Wyspiańskiego 27, Wrocław50-370, Poland.
- Institut Universitaire de France , 5 rue Descartes, Paris75005, France.
- Science for Life Laboratory, Umeå University, Umeå901 87, Sweden.
ORCID profiles: Marco Deiana, Tangui Le Bahers, Cyrille Monnereau, Natacha Gillet, Nasim Sabouri, Laure Guy
Funding
- Narodowe Centrum Nauki
Cite
APA
Sandberg, S. S., Pitrat, D., Labro, M., Azadeh, S. F., Deiana, M., Le Bahers, T., Denis-Quanquin, S., Monnereau, C., Gillet, N., Sabouri, N., & Guy, L. (2026). Benzo[ c ]acridine Dimer Cyclization as a Route toward a Small Bicationic Heteroaromatic Compound with Unprecedented G-Quadruplex Stabilization Properties. ACS Chemical Biology. https://doi.org/10.1021/acschembio.6c00586
Vancouver
Sandberg SS, Pitrat D, Labro M, Azadeh SF, Deiana M, Le Bahers T, et al. Benzo[ c ]acridine Dimer Cyclization as a Route toward a Small Bicationic Heteroaromatic Compound with Unprecedented G-Quadruplex Stabilization Properties. ACS Chemical Biology. 2026. doi:10.1021/acschembio.6c00586
BibTeX
@article{Sandberg2026,
author = {Sandberg, Stefanie Sandra and Pitrat, Delphine and Labro, Marine and Azadeh, Sepideh Farmand and Deiana, Marco and Le Bahers, Tangui and Denis-Quanquin, Sandrine and Monnereau, Cyrille and Gillet, Natacha and Sabouri, Nasim and Guy, Laure},
title = {Benzo[ c ]acridine Dimer Cyclization as a Route toward a Small Bicationic Heteroaromatic Compound with Unprecedented G-Quadruplex Stabilization Properties},
journal = {ACS Chemical Biology},
year = {2026},
doi = {10.1021/acschembio.6c00586}
}
EUVIMED